N-hexadecanoylethanolamineFinding
N-hexadecanoylethanolamine has no detected effect on total nasal symptom score (TNSS)
no difference foundModerate evidenceFinding
01 · The sentence it was drawn from
“No significant difference was seen between the Levagen+ and placebo groups for the allergy symptoms scores (rTNSS) at baseline or throughout the 14 days of treatment.”
N-hexadecanoylethanolamine
Total nasal symptom score (TNSS)
no difference found
- Who
- Adults aged 21 to 77 years with seasonal allergic rhinitis, 108 randomised and 101 completed; whole-population comparison, reflective total nasal symptom score recorded online twice daily
- Dose studied
- Levagen+ (PEA) 350 mg daily, two 175 mg capsules each morning, against placebo of 175 mg maltodextrin per capsule
Moderate evidencePMID 38068797 · 2023
02 · The study
- Study
- RCT
- Duration
- 14 days
Evidence, by strength
- strong
- moderatethis finding
- limited
- very limited
- insufficient
03 · The paper
Nutrients04 · To cite this finding
This address does not changehttps://catalystproject.ai/e/01M7ESDTHR0XQ1B34NPGC3F38M